Skip to content

Clinical trials

Phase 2 Lymphoma, T-Cell, Peripheral trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, T-Cell, Peripheral Phase: Phase 2 Country / region: China Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20111
20141
20151
20161
20171
20183
20191
20206
20212
20223
20234
20246
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status19
Recruiting8
Completed3
Not yet recruiting3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fudan University4
Ruijin Hospital3
Sun Yat-sen University3
Dizal Pharmaceuticals2
Institute of Hematology & Blood Diseases Hospital, China2
Second Affiliated Hospital, Zhejiang University, School of Medicine2
The First Affiliated Hospital with Nanjing Medical University2
BeiGene1
Chengdu Zenitar Biomedical Technology Co., Ltd1
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, T-Cell, Peripheral35
Recurrence5
Lymphoma, T-Cell4
Lymphoma, Large B-Cell, Diffuse2
Lymphoma, Large-Cell, Anaplastic2
Lymphoma, T-Cell, Cutaneous2
Immunoblastic Lymphadenopathy1
Lymphoma, Extranodal NK-T-Cell1
Lymphoma, Mantle-Cell1

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.